The objective of the registry is to evaluate the continued safety and performance of Arthrex Clavicle Plates used to treat clavicle fractures.
To assess safety, device-related adverse events will be reported and evaluated over the course of the study. To evaluate the performance imaging of the target area will be evaluated at three months postoperative. Additionally, patient-reported outcomes will be evaluated at three months postoperative, 6 months postoperative, and one year postoperative using the Visual Analogue Scale (VAS), Veterans Rand 12-Item Health Survey (VR-12), and American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES).
Study Type
OBSERVATIONAL
Arthrex Clavicle Plate for treatment of clavicle fractures
Sierra Pacific Orthpaedic CenterMedical Group, Inc
Fresno, California, United States
Panorama Orthopedics & Spine Center, PC
Golden, Colorado, United States
To assess a change in Visual Analogue Scale (VAS) survey
Patient reported pain scale 0-10 point scale (0 min,10 max)
Time frame: Preoperatively, 3 months, 6 months and 12 months postoperatively
To assess a change in Veterans Rand 12-Item Health Survey (VR-12)
Patient reported changes in general health and mental survey. Average score is 50 (negative answers bring scores down, positive answers bring scores up
Time frame: Preoperatively, 3 months, 6 months and 12 months postoperatively
To assess a change in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)
ASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points.
Time frame: Preoperatively, 3 months, 6 months and 12 months postoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.